Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B)
Authors:
- Asier SelasASAsier Selas
- María FuertesMFMaría Fuertes
- Estela Melcón-FernándezEstela Melcón-Fernández
- Yolanda Pérez-PertejoYPYolanda Pérez-Pertejo
- Rosa M. RegueraRRRosa M. Reguera
- Rafael Balaña-FouceRBRafael Balaña-Fouce
- Birgitta R. KnudsenBKBirgitta R. Knudsen
- Francisco PalaciosFrancisco Palacios
- Concepcion AlonsoConcepcion Alonso
Open Access
- 9 August 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (8) , 784
Abstract
This work describes, for the first time, the synthesis of dialkyl (2-arylquinolin-8-yl)phosphonate derivatives. The preparation was carried out through a direct and simple process as a multicomponent Povarov reaction of aminophenylphosphonates, aldehydes, and styrenes and subsequent oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or, alternatively, by a cycloaddition reaction between phosphonate aldimines and acetylenes. Based on phosphonate group structural characteristics, considered as phosphorous isosteres of carboxylic heterocycles, they may present interesting biological properties related to cell proliferation. In the current report, a new series of dialkyl (2-arylquinolin-8-yl)phosphonates have been synthesized and their antiproliferative effect evaluated on different human cancer and embryonic cells, as well as on Leishmania infantum parasites, a eukaryotic protist responsible for visceral leishmaniasis. Thereby, the antitumor effect was assessed in human lung adenocarcinoma cells (A549), human ovarian carcinoma cells (SKOV3), and human embryonic kidney cells (HEK293) versus the non-cancerous lung fibroblasts cell line (MRC5). On the other hand, the antileishmanial activity was tested against both stages of L. infantum cell cycle, namely free-living promastigotes and intramacrophage amastigotes, using a primary culture of Balb/c splenocytes to calculate the selectivity index. Besides the antiproliferative and antileishmanial capacities, their behavior as topoisomerase 1B inhibitors has been evaluated as a possible mechanism of action.Keywords
Funding Information
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-101818-B-I00)
- Eusko Jaurlaritza (IT 992-16)
- Ministerio de Economía y Competitividad (SAF2017-83575-R)
This publication has 36 references indexed in Scilit:
- Interfacial inhibitors: targeting macromolecular complexesNature Reviews Drug Discovery, 2011
- Structural studies of type I topoisomerasesNucleic Acids Research, 2008
- Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand ComplexesJournal of Medicinal Chemistry, 2006
- A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complexMolecular Cancer Therapeutics, 2006
- Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent ComplexJournal of Medicinal Chemistry, 2005
- A Novel Active DNA Topoisomerase I in Leishmania donovaniJournal of Biological Chemistry, 2003
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Camptothecins Inhibit the Utilization of Hydrogen Peroxide in the Ligation Step of Topoisomerase I CatalysisBiochemistry, 1998
- Bioisosterism: A Rational Approach in Drug DesignChemical Reviews, 1996
- The reactivity of organophosphorus compounds. Part XXV. Displacement of activated aromatic nitro-groups by tervalent phosphorus reagentsJournal of the Chemical Society C: Organic, 1969